Cutaneous Leishmaniasis Treated with Miltefosine: A Case Series of 10 Paediatric Patients
DOI:
https://doi.org/10.2340/00015555-3669Keywords:
leishmaniasis, Leishmania tropica, Leishmania major, miltefosine, amphotericin B, sodium stibogluconateAbstract
Cutaneous leishmaniasis poses a therapeutic challenge in the paediatric population. The aim of this study was to assess the efficacy and safety of miltefosine treatment for Old World cutaneous leishmaniasis in paediatric patients. A multicentre retrospective review of 10 children (??18 years of age) with cutaneous leishmaniasis treated with miltefosine in Israel was performed. Mean???standard deviation age at diagnosis was 9.1???5.0 years. The Leishmania species diagnosed was L. tropica in 8 cases and Leishmania major in 2 cases. Mean???standard deviation duration of treatment was 44.8???20.6 days, with a mean follow-up period of 12.1???17.1 months. Complete response was noted in 8 (80%) patients. Treatment failure was noted in 2 (20%) cases. Side-effects related to the medication were minimal. In conclusion, oral miltefosine may be an effective and safe treatment for Old World cutaneous leishmaniasis caused by Leishmania tropica or Leishmania major in children. However, further studies are warranted to draw a definite conclusion.Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Ayelet Ollech, Michal Solomon, Amir Horev, Shiran Reiss-Huss, Dan Ben-Amitai, Alex Zvulunov, Rivka Friedland, Vered Atar-Snir, Vered Pessach-Molho, Aviv Barzilai, Shoshana Greenberger

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.